In patients with Gitelman syndrome, the corrected QT interval was prolonged in 11 of 21 patients (446-509 ms), but comprehensive cardiac workup revealed no significant arrhythmias or structural issues.
Observational (n=21)
Does primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome) cause significant cardiac arrhythmias or structural abnormalities?
Despite frequent QT prolongation, patients with Gitelman syndrome generally lack significant arrhythmias or structural heart disease on routine cardiac evaluation.
BACKGROUND: Potassium and magnesium depletion prolongs the duration of the action potential of the cardiomyocyte, which predisposes to ventricular arrhythmias. In addition, potassium or magnesium depletion might impair cardiac performance and facilitate coronary artery thrombosis. METHODS: Continuous 24-h ambulatory electrocardiographic monitoring, treadmill exercise testing and echocardiography were assessed in 21 patients (11 female and 10 male subjects, aged 5.9-39, median 19 years) with primary renal hypokalaemia-hypomagnesaemia. RESULTS: The QT interval corrected for heart rate was normal (between 379 and 430 ms) in 10 and slightly to moderately prolonged in the remaining 11 patients (between 446 and 509 ms). Plasma potassium, magnesium and bicarbonate were similar in patients with normal and in those with prolonged QT interval. Continuous ambulatory electrocardiography over 24 h and exercise testing did not detect significant abnormalities of cardiac rhythm or features suggestive of myocardial ischaemia. Finally, echocardiographic and Doppler assessment failed to reveal any abnormalities in myocardial morphology and function. CONCLUSION: The QT interval is often prolonged in primary renal hypokalaemia-hypomagnesaemia, confirming that potassium and magnesium depletion tends to prolong the duration of the action potential of the cardiomyocyte. The results of continuous ambulatory electrocardiography, exercise testing and echocardiography are reassuring. Nonetheless, we assume that dangerous cardiac arrhythmias may occur in patients with very severe hypokalaemia, during medication with drugs that prolong the QT interval or in the context of short-term non-adherence to the recommended regimen of care.
Foglia et al. (Fri,) conducted a observational in Primary renal hypokalaemia-hypomagnesaemia (Gitelman syndrome) (n=21). Cardiac work up (24-h ambulatory ECG, treadmill exercise testing, echocardiography) was evaluated on QT interval, cardiac rhythm abnormalities, myocardial ischaemia, and myocardial morphology/function. In patients with Gitelman syndrome, the corrected QT interval was prolonged in 11 of 21 patients (446-509 ms), but comprehensive cardiac workup revealed no significant arrhythmias or structural issues.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: